With the COVID-19 pandemic continuing to take lives, the distribution of the vaccine is more important than ever. Here in the U.S the vaccine has begun distributing with frontline workers such as doctors and nurses receiving it first. In terms of when normal Americans will be getting the vaccine, experts estimate different timeframes from as early as late February and early March or late in April. But the U.S is only one country, so how is this vaccine getting around the world? Well, each country with an interest in the vaccine had placed orders for when it came out. Despite this, however, many countries are reporting delays.
Specifically, Pfizer was to provide Peru with 10 million vaccine doses in late November but has had this shipment stalled due to clauses in the agreement needing further examination to determine whether they comply with Peruvian law. Other South American countries have raised similar concerns about liability waivers with Pfizer, including Brazil and Argentina.
Many of these concerns stem from views that the vaccine was rushed and that because companies AstraZeneca, Britain’s second largest drug maker, have said they are “granted protection from all legal action if the company’s vaccine led to damaging side effects”.
Pfizer’s stock has recently cooled down from its peak on December 9th. How do you think legal hurdles and safety concerns will affect the already complex logistics of Vaccine distribution?
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.